Autolus Therapeutics plc - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US05280R1005

SecurityAUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership459,404 shares
Latest Disclosed Value $ 633,978
Citadel Advisors Llc ownership in AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 459,404 shares of Autolus Therapeutics plc - Depositary Receipt (Common Stock) (US:AUTL) valued at $633,978 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,159,791 shares of Autolus Therapeutics plc - Depositary Receipt (Common Stock). This represents a change in shares of -60.39% during the quarter. The current value of the position is $702,888 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (AUTL) in the form of stock options. The firm currently holds call options representing 126,400 of underlying shares valued at $174,432 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 459,404 -700,387 -60.39 634 -72.56 0.0001
2026-02-17 2025-12-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 1,159,791 -4,884,452 -80.81 2,308 -76.58 0.0003
2025-11-14 2025-09-30 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 6,044,243 5,039,865 501.79 9,852 330.41 0.0015
2025-08-14 2025-06-30 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 1,004,378 815,470 431.68 2,290 683.90 0.0004
2025-05-15 2025-03-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 188,908 -135,094 -41.70 293 -61.63 0.0001
2025-02-14 2024-12-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 324,002 20,994 6.93 761 -30.76 0.0001
2024-11-14 2024-09-30 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 303,008 -222,780 -42.37 1,100 -39.91 0.0002
2024-08-14 2024-06-30 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 525,788 -160,692 -23.41 1,830 -58.23 0.0004
2024-05-15 2024-03-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 686,480 646,715 1,626.34 4,380 1,610.55 0.0008
2024-02-14 2023-12-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 39,765 39,765 256 0.0001
2023-11-14 2023-09-30 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 0 -185,815 -100.00 0 -100.00
2023-08-14 2023-06-30 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 185,815 -1,379,531 -88.13 442 -84.65 0.0001
2023-05-15 2023-03-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 1,565,346 -211,753 -11.92 2,880 -14.69 0.0006
2023-02-14 2022-12-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 1,777,099 634,494 55.53 3,376 38.08 0.0008
2022-11-14 2022-09-30 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 1,142,605 -1,011,052 -46.95 2,445 -59.89 0.0006
2022-08-15 2022-06-30 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 2,153,657 -1,358,856 -38.69 6,095 -58.39 0.0016
2022-05-16 2022-03-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 3,512,513 1,814,570 106.87 14,647 66.22 0.0030
2022-02-14 2021-12-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 1,697,943 -704,891 -29.34 8,812 -44.01 0.0018
2021-11-15 2021-09-30 13F AUTOLUS THERAPEUTICS Depository Receipt 05280R100 2,402,834 -359,920 -13.03 15,739 -14.20 0.0033
2021-08-16 2021-06-30 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 2,762,754 2,721,085 6,530.24 18,344 7,575.31 0.0041
2021-05-21 2021-03-31 13F/A-1 AUTOLUS THERAPEUTICS SPON ADS 05280R100 41,669 22,661 119.22 239 40.59 0.0001
2021-05-17 2021-03-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 41,669 22,661 239 0.0001
2021-02-16 2020-12-31 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 19,008 5,640 42.19 170 8.97 0.0000
2020-11-16 2020-09-30 13F AUTOLUS THERAPEUTICS SPON ADS 05280R100 13,368 -565,976 -97.69 156 -98.32 0.0000
2020-08-14 2020-06-30 13F AUTOLUS THERAPEUTICS Depository Receipt 05280R100 579,344 -2,360 -0.41 9,287 166.48 0.0033
2020-05-15 2020-03-31 13F AUTOLUS THERAPEUTICS Depository Receipt 05280R100 581,704 570,163 4,940.33 3,485 2,192.76 0.0016
2020-02-14 2019-12-31 13F AUTOLUS THERAPEUTICS Depository Receipt 05280R100 11,541 -59,744 -83.81 152 -86.76 0.0001
2019-08-14 2019-06-30 13F AUTOLUS THERAPEUTICS Depository Receipt 05280R100 71,285 71,285 1,148 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F AUTOLUS THERAPEUTICS SPON ADS Call 126,400 130.24 174 59.63 n/a n/a n/a
2026-02-17 2025-12-31 13F AUTOLUS THERAPEUTICS SPON ADS Call 54,900 357.50 109 473.68 n/a n/a n/a
2025-11-14 2025-09-30 13F AUTOLUS THERAPEUTICS SPON ADS Call 12,000 20 n/a n/a n/a
2025-02-14 2024-12-31 13F AUTOLUS THERAPEUTICS SPON ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F AUTOLUS THERAPEUTICS SPON ADS Call 2,800 -76.07 10 -75.00 n/a n/a n/a
2024-08-14 2024-06-30 13F AUTOLUS THERAPEUTICS SPON ADS Call 11,700 -84.88 41 -91.89 n/a n/a n/a
2024-05-15 2024-03-31 13F AUTOLUS THERAPEUTICS SPON ADS Call 77,400 383.75 494 378.64 n/a n/a n/a
2024-02-14 2023-12-31 13F AUTOLUS THERAPEUTICS SPON ADS Call 16,000 103 n/a n/a n/a
2023-11-14 2023-09-30 13F AUTOLUS THERAPEUTICS SPON ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F AUTOLUS THERAPEUTICS SPON ADS Call 18,100 -33.46 43 -14.00 n/a n/a n/a
2023-05-15 2023-03-31 13F AUTOLUS THERAPEUTICS SPON ADS Call 27,200 -16.31 50 -18.03 n/a n/a n/a
2023-02-14 2022-12-31 13F AUTOLUS THERAPEUTICS SPON ADS Call 32,500 62 n/a n/a n/a
2022-11-14 2022-09-30 13F AUTOLUS THERAPEUTICS SPON ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F AUTOLUS THERAPEUTICS SPON ADS Call 18,600 53 n/a n/a n/a
2022-05-16 2022-03-31 13F AUTOLUS THERAPEUTICS SPON ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F AUTOLUS THERAPEUTICS SPON ADS Call 36,900 -56.38 192 -65.34 n/a n/a n/a
2021-11-15 2021-09-30 13F AUTOLUS THERAPEUTICS Depository Receipt Call 84,600 554 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F AUTOLUS THERAPEUTICS SPON ADS Put 0 -100.00 0 n/a n/a n/a
2025-11-14 2025-09-30 13F AUTOLUS THERAPEUTICS SPON ADS Put 25,300 -11.85 41 -36.92 n/a n/a n/a
2025-08-14 2025-06-30 13F AUTOLUS THERAPEUTICS SPON ADS Put 28,700 -62.19 65 -44.44 n/a n/a n/a
2025-05-15 2025-03-31 13F AUTOLUS THERAPEUTICS SPON ADS Put 75,900 179.04 118 85.71 n/a n/a n/a
2025-02-14 2024-12-31 13F AUTOLUS THERAPEUTICS SPON ADS Put 27,200 3,300.00 64 3,050.00 n/a n/a n/a
2024-11-14 2024-09-30 13F AUTOLUS THERAPEUTICS SPON ADS Put 800 -72.41 3 -80.00 n/a n/a n/a
2024-08-14 2024-06-30 13F AUTOLUS THERAPEUTICS SPON ADS Put 2,900 -61.84 10 -79.17 n/a n/a n/a
2024-05-15 2024-03-31 13F AUTOLUS THERAPEUTICS SPON ADS Put 7,600 130.30 48 128.57 n/a n/a n/a
2024-02-14 2023-12-31 13F AUTOLUS THERAPEUTICS SPON ADS Put 3,300 21 n/a n/a n/a
2023-11-14 2023-09-30 13F AUTOLUS THERAPEUTICS SPON ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F AUTOLUS THERAPEUTICS SPON ADS Put 7,000 -4.11 17 23.08 n/a n/a n/a
2023-05-15 2023-03-31 13F AUTOLUS THERAPEUTICS SPON ADS Put 7,300 356.25 13 333.33 n/a n/a n/a
2023-02-14 2022-12-31 13F AUTOLUS THERAPEUTICS SPON ADS Put 1,600 3 n/a n/a n/a
2022-05-16 2022-03-31 13F AUTOLUS THERAPEUTICS SPON ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F AUTOLUS THERAPEUTICS SPON ADS Put 21,400 -52.13 111 -62.12 n/a n/a n/a
2021-11-15 2021-09-30 13F AUTOLUS THERAPEUTICS Depository Receipt Put 44,700 293 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.